Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas
1998
(57) Abstract: The present invention is the use of a series of aryl ureas in treating raf mediated diseases, to pharmaceutical compositions for use in such therapy.
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI